Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe 5mg Mounjaro KwikPen is not designed to deliver a 2.5mg dose. Each pen is pre-set at a single, fixed strength — clicking the button once delivers the full 5mg dose, and there is no mechanism to dial down to half that amount. If your prescriber has you on the 2.5mg starting dose, the right pen is the 2.5mg KwikPen, not the 5mg. This is a prescription-only medicine, and dose decisions sit with your prescriber and the Patient Information Leaflet, not with counting clicks.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people ask how many clicks of the 5mg Mounjaro pen produce a 2.5mg dose, working from the reasonable-sounding logic that half the strength must mean half the clicks. It is an understandable assumption, and it is completely wrong, gently, but firmly worth knowing before you do anything else.
The Mounjaro KwikPen is not a variable-dose device. There is no dial, no click-counter and no way to interrupt the injection mid-way to get a smaller amount. When you press the button, the pen delivers its entire pre-filled dose in one automated movement. On a 5mg pen, that is always 5mg. On a 2.5mg pen, always 2.5mg. The mechanism does not allow for fractions. Attempting to stop an injection early or repeat-click in the hope of titrating the dose does not produce a reliable result and is not a technique described anywhere in the licensed prescribing information. The Mounjaro overview page covers how the KwikPen works in more detail if you want the fuller picture.
The NHS patient information for tirzepatide is clear that dosing must follow the prescriber's instructions and the leaflet enclosed with the pen; anything outside that is off-label use at best and a dosing error at worst. The NHS medicines page for tirzepatide is a good first reference if you want to check that against an authoritative source.
Treatment with Mounjaro starts at 2.5mg once a week, for the first four weeks. This dose exists specifically to let your system adjust before any therapeutic effect kicks in, the first pen's job is settling your tolerance, not driving weight loss. That dose comes in its own dedicated KwikPen, prescribed and dispensed at 2.5mg.
If you are currently on the 2.5mg starting dose and wondering about the mechanics of that pen specifically, the guide to the 2.5mg dose from a 5mg pen addresses the closest related question, though the short answer there is the same: the pens are not interchangeable for dose purposes. And if your prescriber has recently moved you up and you are curious about what comes next in the schedule, the 7.5mg KwikPen page explains that pen's fixed-dose setup.
The six licensed UK strengths (2.5, 5, 7.5, 10, 12.5 and 15mg) each correspond to a separate pen. Titration means moving from one pen to the next at the prescriber's direction, typically in four-week steps when the previous dose is well tolerated. It does not mean adapting the pen you already have. That is how Eli Lilly designed the system, and it is how the UK licence works.
Mounjaro is a Black Triangle (▼) medicine, meaning it is under additional MHRA monitoring while post-market safety data accumulates. Getting the dose right is part of that safety picture. An unintended underdose from a failed half-click attempt could mean poor tolerability management (you miss the gradual titration that protects against nausea) while an unintended overdose, if the pen fires fully when you expected half, carries its own risks.
The broader point: these pens arrive as part of a prescription, reviewed by a real clinician who has chosen the specific strength for a reason. Trying to adapt one pen into another dose is not a workaround, it is a change to your treatment that bypasses that clinical decision. If the pen you have does not match the dose your prescriber intended, the right call is to contact your prescriber or pharmacy, not to improvise. Our contact page is there if you need to reach the team at nume.
A useful broader note: anyone researching Mounjaro pens online should make sure they are sourcing through a pharmacy registered with the GPhC, the guide to buying Mounjaro online explains what to check. Fake pens sold outside regulated channels have been seized in large quantities by the MHRA, and a counterfeit pen's dose behaviour is entirely unpredictable. For context on a separate but related risk, the Mounjaro golden dose warning page covers a common titration misconception worth reading alongside this one.
If you have questions about your specific pen or dose that go beyond general information, speaking to our prescribers is the right next step, they review consultations the same day and can give you a clear answer about your own treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.